Abstract:Background: Pneumonia is an infection of the pulmonary parenchyma, causing significant morbidity and mortality. Inflammation potentiates hypoalbuminemia. CRP is an acute phase reactant produced by the liver in response to inflammation, which depends on severity of illness. Serum albumin concentration as a negative acute phase reactant, changes with change in CRP(C-reactive protein) value. Objectives: To study the prognostic significance of commonly used biomarkers serum Albumin level and C - reactive protein in hospitalized patients with Community Acquired Pneumonia. Methodology: The prospective study was conducted in a hospital affiliated to Vijayanagara Institute of Medical Science, Ballari. Patients with signs and symptoms of CAP were hospitalized based on a CURB-65 score. After informed consent, all relevant data was collected. Clinical examination and laboratory parameters i.e. Serum albumin & C - reactive protein levels on day 1, 3 & 7/discharge were carried out. The values of serum albumin & C - reactive protein were analyzed with the clinical profile and outcome in these study groups. Results: In our study, CAP was more commonly seen among the age group of 61-70 yrs (27%). COPD was a major associated co-morbidity (50%) and smoking was an important risk factor (70%). The majority had a CURB 65 score of >3-5 on admission (64%). Out of 50 patients, 26% of them had severe hypoalbuminemia (<2.5 mg/dl) and 58% of them had mild hypoalbuminemia (2.5-3.5 mg/dl) on day 1 of admission. When serum albumin levels at the time of admission were analyzed for the time of discharge, there was significant change (P=0.025) noted, i.e an increase in serum albumin levels were seen in all patients who had clinical signs of resolution. 38% of patients had serum CRP levels 200 mg/l. There was decrease in CRP level at the time of discharge (p=0.001). Serum Albumin levels and CRP levels showed significant change from day 1 to the day of discharge (p=0.025 and P=<0.001) respectively. ICU requirement, need for mechanical ventilation and other outcomes correlated well with serum albumin levels (p=0.021, p=0.004, p=0.003 respectively). Conclusion: Our study showed a history of smoking, COPD and hypoalbuminemia at presentation were major risk factors present for CAP. Patients with severe hypoalbuminemia had high morbidity and mortality in the form of ICU requirement, need for mechanical ventilation, complications and death. CRP serves as an important marker of inflammation whose series levels reduce significantly with cure / resolution of pneumonia. Thus, serum albumin levels and C reactive protein can be used as a prognostic biomarker in community acquired pneumonia.

The significance of serum electrolyte levels as a prognostic marker in acute exacerbations of COPD – A hospital-based case control study

ELECTROLYTE DISTURBANCES IN ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT SMS MEDICAL COLLEGE, JAIPUR

Serum Electrolytes in Patients Presenting With Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) and Their Comparison With Stable COPD Patients

A prospective study of the predictors of mortality in acute exacerbation of COPD: an Indian perspective

The role of serum chloride ion in the prognosis of COPD

Sodium and potassium disorders in patients with COPD exacerbation presenting to the emergency department

Study of Inflammatory Markers in Chronic Obstructive Pulmonary Disease

Prognostic significance of eosinophil-to-platelet ratio and C-reactive protein in predicting adverse events during acute exacerbations of chronic obstructive pulmonary disease: A comprehensive observational study

Serum lactate dehydrogenase and its isoenzymes as predictors of clinical outcomes in acute exacerbation of chronic obstructive pulmonary disease: a retrospective analysis of a hospitalized cohort

Study of inflammatory biomarkers in Chronic obstructive pulmonary disease (COPD) and their association with comorbidities

Assessment of Serum Electrolytes, Biochemical, and Inflammatory Markers in Predicting COVID-19 Severity in COPD Patients

Predicting outcomes following hospitalization for acute exacerbations of COPD

Serum Albumin And C-reactive Protein as Prognostic Biomarkers in Hospitalised Patients with Community Acquired Pneumonia

Use of the Serum Level of Cholinesterase as a Prognostic Marker of Nonfatal Clinical Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Admission blood eosinophil count, inpatient death and death at 1 year in exacerbating patients with COPD

Biomarkers as a Prognostic Factor in COPD Exacerbation: A Cohort Study

Predictors of Mortality in Hospitalized Adults with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis

Association Between the Serum Phosphate Levels and Hospital Mortality as Well as 90-Day Mortality Among Critically Ill Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study

Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future

The importance of the erythrocyte distribution width/albumin ratio in patients with chronic obstructive pulmonary disease exacerbation

Blood eosinophil variability in patients presenting with acute exacerbations of COPD within the past year and its correlation with treatment plan